Life Science & Technology Weekly 151 – RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater China

Cannabis, Life Science

B.C. signs agreements with licensed producers to supply legal marijuana

Cannabis, Life Science

Canopy to acquire Tokyo Smoke parent company in $250 million retail play

Cannabis, Life Science

Cannabis grower Tilray valued at up to US$1.5 billion for Nasdaq IPO

Cannabis, Life Science

Alberta signs pot supply deals with 13 licensed marijuana producers

Cannabis, Life Science

Switzerland weighs relaxing marijuana ban

Cannabis, Life Science

Britain moves closer to legalizing medicinal use of cannabis

Cannabis, Life Science

Energy and pot stocks help TSX to best quarter in 4 years

Cannabis, Life Science

Cannabis-Based Drug Developers Are Hopeful as FDA Approves First Marijuana-based Seizure Treatment

Cannabis, Life Science

Aurora lines up $250-million loan deal with BMO, calling it industry’s largest to date

Cannabis, Life Science

U.S. approves first marijuana plant-derived drug for epilepsy

Cannabis, Life Science

Key marijuana drug approval looms as cannabis goes mainstream

Cannabis, Life Science

Canada sets October start for legal recreational marijuana sales

Cannabis, Life Science

Tilray marijuana products to start carrying drugmaker Sandoz name

Cannabis, Life Science

New York plans to allow medical cannabis as opioid substitute

Cannabis, Life Science